Abstract | OBJECTIVES: METHODS: RESULTS: The serum levels of endostatin and MMP-9 were significantly greater in the 52 patients with bladder cancer than in the healthy controls ( endostatin 46.8 ng/mL versus 30.6 ng/mL, P <0.001; MMP-9 786 ng/mL versus 417 ng/mL, P <0.001). The endostatin level correlated positively with the MMP-9 level (R = 0.55, P <0.01). Furthermore, the levels of endostatin and MMP-9 were associated with the tumor stage and grade. Patients with distant metastasis (n = 7) had significantly greater levels of endostatin and MMP-9 than patients without metastasis (n = 45) ( endostatin 69.8 ng/mL versus 43.3 ng/mL, P <0.001; MMP-9 1529 ng/mL versus 674 ng/mL, P <0.001). CONCLUSIONS:
|
Authors | Kao-Peng Guan, Hai-Yun Ye, Zheng Yan, Ying Wang, Shu-Kun Hou |
Journal | Urology
(Urology)
Vol. 61
Issue 4
Pg. 719-23
(Apr 2003)
ISSN: 1527-9995 [Electronic] United States |
PMID | 12670552
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endostatins
- Peptide Fragments
- Collagen
- Matrix Metalloproteinase 9
|
Topics |
- Carcinoma, Transitional Cell
(blood, enzymology, pathology)
- Collagen
(blood)
- Endostatins
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Matrix Metalloproteinase 9
(blood)
- Middle Aged
- Neoplasm Staging
- Peptide Fragments
(blood)
- Urinary Bladder
(pathology)
- Urinary Bladder Neoplasms
(blood, enzymology, pathology)
|